Lorenzo F. Fanchi

Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers

Myriam Chalabi, Lorenzo F. Fanchi, Krijn K. Dijkstra et al. · Nature Medicine · 2020 · 1.3K citations · Full text

Neoadjuvant Immunotherapy, Tumor Immunology, Cancer Immunosurveillance +11

Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids

Krijn K. Dijkstra, Chiara M. Cattaneo, Fleur Weeber et al. · Cell · 2018 · 1K citations · Full text

Tumor-reactive T Cells, Cell Therapy, Cancer Immunosurveillance +10

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

Christian U. Blank, Elisa A. Rozeman, Lorenzo F. Fanchi et al. · Nature Medicine · 2018 · 833 citations

Medicine, Melanoma, Immunology +6

Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers

Wouter Scheper, Sander Kelderman, Lorenzo F. Fanchi et al. · Nature Medicine · 2018 · 556 citations

Cancer Immunosurveillance, Intratumoral Tcr Repertoire, Medicine +11

Tumor organoid–T-cell coculture systems

Chiara Cattaneo, Krijn K. Dijkstra, Lorenzo F. Fanchi et al. · Nature Protocols · 2019 · 344 citations · Full text

Cell Culture, Organoid Models, Organogenesis +6